מודל פתוח דו-מדורי: עירוי תוך-ורידי

The two-compartment model consists of a central compartment, where drug elimination occurs, and a peripheral compartment. The central compartment represents highly perfused tissues like blood and organs, while the peripheral compartment represents less perfused tissues. This structure allows the model to describe how drugs distribute between these tissue groups during constant-rate intravenous infusion.

At steady-state conditions, the drug's input rate equals its elimination rate, resulting in a constant plasma concentration. When this equilibrium is reached, certain terms in the pharmacokinetic equation become zero, simplifying calculations. This relationship is fundamental for predicting when a drug will maintain stable therapeutic levels during continuous intravenous infusion.

The loading dose is calculated using a formula where Vc represents the apparent volume of distribution of the central compartment, and Css is the steady-state concentration. The loading dose equals Vc multiplied by the desired Css. This calculation ensures that the drug rapidly achieves therapeutic concentrations in the central compartment before maintenance infusion begins.

Plasma drug concentration decreases from the central compartment because elimination occurs there during constant-rate intravenous infusion. As the drug is metabolized or excreted from the central compartment, its concentration declines until reaching steady-state, where input and elimination rates balance. The two-compartment model depicts this dynamic process through a specific mathematical equation.

The two-compartment model allows estimation of key pharmacokinetic parameters including the apparent volume of distribution, elimination rate constant, and clearance. These parameters are essential for calculating loading doses and maintenance doses. The model provides invaluable information for dosing strategies and therapeutic monitoring in clinical practice.

The two-compartment model accounts for drug distribution between central and peripheral compartments, providing more realistic predictions than simpler models. Unlike single-compartment approaches, it recognizes that drugs distribute unevenly across tissues and that elimination occurs specifically from the central compartment. This complexity enables more accurate dosing decisions and therapeutic monitoring for drugs with complex distribution patterns.

The two-compartment IV infusion model supports clinical dosing by enabling calculation of loading doses and estimation of pharmacokinetic parameters needed for individualized therapy. By accurately predicting steady-state concentrations and drug elimination patterns, it helps healthcare providers optimize drug administration and maintain therapeutic levels. This model is essential for therapeutic drug monitoring and preventing subtherapeutic or toxic exposures.